Current directions, conceptions and viewpoints on 2019‑nCoV (Review)
- Authors:
- Xiao Feng
- Xiaoyu Xie
- Shouyang Song
- Wenjun Chen
- Hongjun Bian
- Fajuan Rui
- Qiang Zhu
- Wanhua Ren
- Chengyong Qin
- Jianni Qi
-
Affiliations: Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250021, P.R. China, Department of Emergency Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Department of Infectious Disease, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China, Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, P.R. China - Published online on: November 25, 2020 https://doi.org/10.3892/etm.2020.9502
- Article Number: 70
-
Copyright: © Feng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395:497–506. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Calligari P, Bobone S, Ricci G and Bocedi A: Molecular investigation of SARS-CoV-2 proteins and their interactions with antiviral drugs. Viruses. 12(445)2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, Trilling M, Lu M, Dittmer U and Yang D: Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 92:491–494. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, et al: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 382:727–733. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chu H, Chan JF, Wang Y, Yuen TT, Chai Y, Hou Y, Shuai H, Yang D, Hu B, Huang X, et al: Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 71:1400–1409. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ammad Ud Din M and Boppana LK: An update on the 2019-nCoV outbreak. Am J Infect Control. 48(713)2020.PubMed/NCBI View Article : Google Scholar | |
|
National Health Commission of the People's Republic of China. urihttp://www.nhc.gov.cn/simplehttp://www.nhc.gov.cn/. Accessed November, 2020. | |
|
Johns Hopkins University and Medicine. urihttps://coronavirus.jhu.edu/map.htmlsimplehttps://coronavirus.jhu.edu/map.html. Accessed November, 2020. | |
|
Bulut C and Kato Y: Epidemiology of COVID-19. Turk J Med Sci. 50:563–570. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cai H: Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 8(e20)2020.PubMed/NCBI View Article : Google Scholar | |
|
Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R and Klein SL: Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 11(29)2020.PubMed/NCBI View Article : Google Scholar | |
|
La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A and Calogero AE: Sex-specific SARS-CoV-2 mortality: Among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int J Mol Sci. 21(2948)2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang Y, Wang Y, Chen Y and Qin Q: Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 92:568–576. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Benvenuto D, Giovanetti M, Ciccozzi A, Spoto S, Angeletti S and Ciccozzi M: The 2019-new coronavirus epidemic: Evidence for virus evolution. J Med Virol. 92:455–459. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Salata C, Calistri A, Parolin C and Palu G: Coronaviruses: A paradigm of new emerging zoonotic diseases. Pathog Dis. 77(ftaa006)2019.PubMed/NCBI View Article : Google Scholar | |
|
Chen J: Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes Infect. 22:69–71. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL and Zhou P: Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes. Emerg Microbes Infect. 9:386–389. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ceraolo C and Giorgi FM: Genomic variance of the 2019-nCoV coronavirus. J Med Virol. 92:522–528. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Baruah V and Bose S: Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol. 92:495–500. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Morse JS, Lalonde T, Xu S and Liu WR: Learning from the Past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem. 21:730–738. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kannan S, Shaik Syed Ali P, Sheeza A and Hemalatha K: COVID-19 (Novel Coronavirus 2019)-recent trends. Eur Rev Med Pharmacol Sci. 24:2006–2011. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Vankadari N and Wilce JA: Emerging WuHan (COVID-19) coronavirus: Glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 9:601–604. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kumar S, Maurya VK, Prasad AK, Bhatt MLB and Saxena SK: Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease. 31:13–21. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, et al: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 395:565–574. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 63:364–374. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang K, Chen W, Zhou YS, Lian JQ, Zhang Z, Du P, Gong L, Zhang Y, Cui HY, Geng JJ, et al: SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv: Mar 14, 2020 (Epub ahead of print). doi: urihttps://doi.org/10.1101/2020.03.14.988345simplehttps://doi.org/10.1101/2020.03.14.988345. | |
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report of three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y and Zuo W: Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV. bioRxiv: Jan 26, 2020 (Epub ahead of print). doi: urihttps://doi.org/10.1101/2020.01.26.919985simplehttps://doi.org/10.1101/2020.01.26.919985. | |
|
Wang C, Xie J, Zhao L, Fei X, Zhang H, Tan Y, Zhou L, Liu Z, Ren Y, Yuan L, et al: Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19. Res Square: Mar 25, 2020 (Epub ahead of print). doi: urihttps://doi.org/10.21203/rs.3.rs-19346/v1simplehttps://doi.org/10.21203/rs.3.rs-19346/v1. | |
|
Angel-Korman A, Brosh T, Glick K and Leiba A: COVID-19, the kidney and hypertension. Harefuah. 159:231–234. 2020.PubMed/NCBI | |
|
Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, Zhou J, Shi G, Fang N, Fan J, et al: Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv: Feb 4, 2020 (Epub ahead of print). doi: 10.1101/2020.02.03.931766. | |
|
Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM and Lu FM: Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi. 28:100–106. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, et al: SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181:271–280.e8. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y and Zhou Y: Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: A systematic review and meta-analysis. Int J Infect Dis. 94:91–95. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z and Zhao Y: Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 109:531–538. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Wang W, Tang J and Wei F: Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 92:441–447. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, et al: Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77:683–690. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY and Zheng MH: COVID-19 and liver dysfunction: Current insights and emergent therapeutic strategies. J Clin Transl Hepatol. 8:18–24. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen L, Liu M, Zhang Z, Qiao K, Huang T, Chen M, Xin N, Huang Z, Liu L, Zhang G and Wang J: Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 104:748–751. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave-Roblot F and Masson Regnault M: Comment on ‘Cutaneous manifestations in COVID-19: A first perspective’ by Recalcati S. J Eur Acad Dermatol Venereol. 34:e299–e300. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Cui S, Chen S, Li X, Liu S and Wang F: Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 18:1421–1424. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Singhal T: A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr. 87:281–286. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen L, Liu HG, Liu W, Liu J, Liu K, Shang J, Deng Y and Wei S: Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:203–208. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Jin Y, Wang M, Zuo Z, Fan C, Ye F, Cai Z, Wang Y, Cui H, Pan K and Xu A: Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019. Int J Infect Dis. 94:49–52. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tobin MJ: Basing respiratory management of COVID-19 on physiological principles. Am J Respir Crit Care Med. 201:1319–1320. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ganji A, Farahani I, Khansarinejad B, Ghazavi A and Mosayebi G: Increased expression of CD8 marker on T-cells in COVID-19 patients. Blood Cells Mol Dis. 83(102437)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, Ng DYM, Wan CKC, Yang P, Wang Q, et al: Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin Chem. 66:549–555. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, Li L, He R, Tan Y, Deng X, et al: Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect. 9:469–473. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Peng L, Liu J, Xu W, Luo Q, Chen D, Lei Z, Huang Z, Li X, Deng K, Lin B and Gao Z: SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J Med Virol, Apr 24, 2020 (Online ahead of print). | |
|
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brünink S, Schneider J, Schmidt ML, et al: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 25(2000045)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chan JF, Yip CC, To KK, Tang TH, Wong SC, Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, et al: Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel Real-time reverse transcription-PCR assay validated in vitro and with clinical specimens. J Clin Microbiol. 58:e00310–20. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Ferrari D, Motta A, Strollo M, Banfi G and Locatelli M: Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem Lab Med. 58:1095–1099. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tian S, Hu W, Niu L, Liu H, Xu H and Xiao SY: Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 15:700–704. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Yao XH, Li TY, He ZC, Ping YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WJ, et al: A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 49:411–417. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Li H, Wang YM, Xu JY and Cao B: Potential antiviral therapeutics for 2019 novel coronavirus. Zhonghua Jie He He Hu Xi Za Zhi. 43:170–172. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Liu X, Li Z, Liu S, Sun J, Chen Z, Jiang M, Zhang Q, Wei Y, Wang X, Huang YY, et al: Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B. 10:1205–1215. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL and Bhattoa HP: Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 12(988)2020.PubMed/NCBI View Article : Google Scholar | |
|
Fan HH, Wang LQ, Liu WL, An XP, Liu ZD, He XQ, Song LH and Tong YG: Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin Med J (Engl). 133:1051–1056. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Joshi RS, Jagdale SS, Bansode SB, Shankar SS, Tellis MB, Pandya VK, Chugh A, Giri AP and Kulkarni MJ: Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J Biomol Struct Dyn: May 5, 2020 (Epub ahead of print). doi: 10.1080/07391102.2020.1760137. | |
|
Serseg T, Benarous K and Yousfi M: Hispidin and Lepidine E: Two natural compounds and folic acid as potential inhibitors of 2019-novel coronavirus main protease (2019-nCoVMpro), molecular docking and SAR study. Curr Comput Aided Drug Des: Apr 21, 2020 (Epub ahead of print). | |
|
Abena PM, Decloedt EH, Bottieau E, Suleman F, Adejumo P, Sam-Agudu NA, Muyembe TamFum JJ, Seydi M, Eholie SP, Mills EJ, et al: Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: Caution for inappropriate off-label use in healthcare settings. Am J Trop Med Hyg. 102:1184–1188. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Tufan A, Avanoğlu Güler A and Matucci-Cerinic M: COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci. 50:620–632. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Shetty AK: Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia. Aging Dis. 11:462–464. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Sun ML, Yang JM, Sun YP and Su GH: Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:219–222. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Kong LM, Liao CG, Zhang Y, Xu J, Li Y, Huang W, Zhang Y, Bian H and Chen ZN: A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis. Cancer Res. 74:3764–3778. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Qin YY, Zhou YH, Lu YQ, Sun F, Yang S, Harypursat V and Chen YK: Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: Protocol of a randomized controlled trial. Chin Med J (Engl). 133:1080–1086. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Choudhury R, Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Talmor DS, Nydam TL and Yaffe MB: Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: A Markov decision analysis. World J Emerg Surg. 15(29)2020.PubMed/NCBI View Article : Google Scholar | |
|
Taniguchi H, Ogawa F, Honzawa H, Yamaguchi K, Niida S, Shinohara M, Takahashi K, Iwashita M, Abe T, Kubo S, et al: Veno-venous extracorporeal membrane oxygenation for severe pneumonia: COVID-19 case in Japan. Acute Med Surg. 7(e509)2020.PubMed/NCBI View Article : Google Scholar | |
|
Omolo CA, Soni N, Fasiku VO, Mackraj I and Govender T: Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus. Eur J Pharmacol. 883(173348)2020.PubMed/NCBI View Article : Google Scholar |
